(1) Background: Homer-3
antibodies are associated with
cerebellar disease ranging from subacute degeneration to cerebellitis. However,
cognitive impairment associated with Homer-3
autoantibodies has not been reported until now. (2) Methods: in retrospect, we systematically studied clinical, cranial magnetic resonance imaging (cMRI), electroencephalography (EEG) and lumbar puncture data, including neural
autoantibodies of a clinical case. (3) Results: we describe the case of a 56-year-old woman presenting with amnestic
mild cognitive impairment in association with serum and CSF detection of Homer-3
autoantibodies and a
depressive syndrome. cMRI revealed cerebellar
atrophy. CSF analysis showed elevated ptau181
protein. Applying the criteria for an autoimmune psychiatric syndrome revealed a plausible autoimmune basis for the
mild cognitive impairment. (4) Discussions: our case report demonstrates an amnestic
mild cognitive impairment and depressive symptoms associated with Homer-3
autoantibodies as a novel feature of Homer-3 antibody-related disease. We also propose that
cognitive dysfunction might result from impaired AMPAR signaling in the hippocampus induced by Homer-3
antibodies, which will have to be verified in further research.